003017 大洋生物
按盤價 
20.990 -0.830 (-3.804%)
20.990 -0.830 (-3.804%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.686 | 9.145 | 6.188 | 5.018 | 8.172 |
| 總資產報酬率 ROA (%) | 1.670 | 5.752 | 3.984 | 3.274 | 5.601 |
| 投入資產回報率 ROIC (%) | 1.864 | 6.444 | 4.438 | 3.700 | 6.241 | 邊際利潤分析 |
| 銷售毛利率 (%) | 23.459 | 22.898 | 19.550 | 18.084 | 13.822 |
| 營業利潤率 (%) | 12.512 | 10.538 | 8.283 | 6.122 | 5.594 |
| 息稅前利潤/營業總收入 (%) | 12.398 | 9.824 | 7.530 | 4.879 | 5.619 |
| 淨利潤/營業總收入 (%) | 11.111 | 9.572 | 7.004 | 5.439 | 7.629 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.924 | 96.921 | 91.100 | 95.717 | 61.628 |
| 價值變動淨收益/利潤總額(%) | -0.354 | -0.266 | 0.509 | 3.495 | 5.075 |
| 營業外收支淨額/利潤總額(%) | -0.113 | -3.108 | -5.199 | -19.804 | -3.028 | 償債能力分析 |
| 流動比率 (X) | 1.225 | 1.219 | 1.216 | 1.538 | 1.523 |
| 速動比率 (X) | 1.053 | 1.049 | 1.005 | 1.184 | 1.257 |
| 資產負債率 (%) | 37.614 | 37.489 | 36.310 | 34.814 | 34.681 |
| 帶息債務/全部投入資本 (%) | 30.211 | 27.485 | 27.590 | 23.805 | 22.474 |
| 股東權益/帶息債務 (%) | 225.601 | 257.216 | 254.538 | 308.124 | 329.963 |
| 股東權益/負債合計 (%) | 165.135 | 165.999 | 175.243 | 187.237 | 188.341 |
| 利息保障倍數 (X) | -123.748 | -24.773 | -21.920 | -21.119 | 29.751 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 34.411 | 25.076 | 19.225 | 21.031 | 17.565 |
| 存貨周轉天數 (天) | 46.513 | 50.790 | 66.884 | 66.702 | 56.946 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 17/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
